Granulocyte-Macrophage Colony-Stimulating Factor: all 118 studies that test it

Page 1 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.

• Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCLRecruitingNCT07749365Phase 2
• Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar ProteinosisNot yet recruitingNCT06989333Phase 2
• The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving RadiotherapyRecruitingNCT06472739Phase 2
• NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) TrialRecruitingNCT06450041Phase 2
• PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study)Not yet recruitingNCT06345599Phase 1/2
• Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck TumorsRecruitingNCT05760196Phase 2
• Quadruple Immunotherapy for NeuroblastomaRecruitingNCT05754684Phase 2
• PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors.Not yet recruitingNCT05530200Phase 2
• ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and PembrolizumabNot yet recruitingNCT05366062Phase 2
• A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With NeuroblastomaRecruitingNCT04936529Phase 2
• Autologous Stem Cell Transplantation in Patients With Systemic SclerosisRecruitingNCT03630211Phase 2
• A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaCompletedNCT04238819Phase 1/2Results posted
• Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated GliomaTerminatedNCT03927222Phase 2Results posted
• GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS StudyCompletedNCT03769844Phase 4Results posted
• First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699TerminatedNCT03426995Phase 1Results posted
• Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy SubjectsCompletedNCT03306589Phase 1Results posted
• Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian CancerTerminatedNCT02978222Phase 2Results posted
• Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll MelanomaCompletedNCT02451488Phase 4Results posted
• Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk NeuroblastomaCompletedNCT02100930Not applicableResults posted
• Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma MultiformeCompletedNCT02078648Phase 1/2Results posted
• A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma PatientsCompletedNCT02009397Phase 1/2Results posted
• Therapy for Children With Advanced Stage NeuroblastomaCompletedNCT01857934Phase 2Results posted
• WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell TransplantationCompletedNCT01827137Phase 1/2Results posted
• ch14.18 Pharmacokinetic Study in High-risk NeuroblastomaCompletedNCT01592045Phase 1/2Results posted
• Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVaxCompletedNCT01570036Phase 2Results posted
• Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)TerminatedNCT01542684Phase 2Results posted
• Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)CompletedNCT01408901Not applicableResults posted
• A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerCompletedNCT01322490Phase 3Results posted
• WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)CompletedNCT01266083Phase 2Results posted
• Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality TherapyCompletedNCT01265433Phase 2Results posted
• Granulocyte-Macrophage Stimulating Factor in the Treatment of Peripheral Arterial DiseaseCompletedNCT01041417Phase 2Results posted
• Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic LeukemiaCompletedNCT00940342Phase 2Results posted
• Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSFCompletedNCT00661622Phase 2Results posted
• Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic TransplantationCompletedNCT00548847Phase 2Results posted
• Chemoimmunotherapy Study for Patients With Epithelial Ovarian CancerCompletedNCT00501644Phase 2Results posted
• G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL PatientsCompletedNCT00499343Phase 2Results posted
• Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00488982Phase 2Results posted
• Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate CancerTerminatedNCT00477087Phase 2Results posted
• Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSFCompletedNCT00458536Phase 1/2Results posted
• Herceptin and GM-CSF for Metastatic Breast CancerCompletedNCT00429104Phase 2Results posted
• GM-CSF for Maintenance of Prostate Cancer for Patients Responding to TaxotereCompletedNCT00274287Phase 2Results posted
• Cellular Immune Augmentation in Colon and Rectal CancerCompletedNCT00257322Phase 2Results posted
• Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and RituximabTerminatedNCT00208975Phase 2Results posted
• A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSFTerminatedNCT00208949Phase 2Results posted
• A Randomized Trial of GM-CSF in Patients With ALI/ARDSCompletedNCT00201409Phase 2Results posted
• GM-CSF, Sargramostim in Women With Recurrent Ovarian CancerCompletedNCT00157573Phase 2Results posted
• PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney CancerTerminatedNCT00090870Phase 2Results posted
• Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)Status unknownNCT05603013Phase 2
• Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical ResectionActive, not recruitingNCT05307835Phase 1
• Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRCStatus unknownNCT05292417Phase 2
• GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODSCompletedNCT05266001Phase 3
• GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA SurgeryStatus unknownNCT04979832Phase 1/2
• Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal CancerStatus unknownNCT04929652Phase 1/2
• Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)Status unknownNCT04892498Phase 2
• Metastatic Solid Cancer Clinical TrialActive, not recruitingNCT04739618Phase 2
• A Phase 2 Trial for Patients With Metastatic Solid CancerActive, not recruitingNCT04713371Phase 2
• Study of the Effect of GM-CSF on Macrophages in EpendymomaCompletedNCT04408092Early Phase 1
• SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLCStatus unknownNCT04106180Phase 2
• The Effect of the GM-CSF Gel on the Endometrial Thickness in Infertile Women With Thin EndometriumStatus unknownNCT04100655Not applicable
• Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone MarrowActive, not recruitingNCT03363373Phase 2
• Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar ProteinosisStatus unknownNCT03316651Phase 2
• Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial DiseaseCompletedNCT03304821Phase 2
• REO13 Melanoma With of Without GM-CSFWithdrawnNCT03282188Phase 1/2
• Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRCWithdrawnNCT03222089Phase 2
• Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With CirrhosisStatus unknownNCT03123666Not applicable
• A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk NeuroblastomaCompletedNCT03033303Phase 2
• Miltefosine and GM-CSF in Cutaneous LeishmaniasisCompletedNCT03023111Phase 3
• G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant TumorStatus unknownNCT02933333Phase 4
• Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT02663440Phase 2
• Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent OsteosarcomaActive, not recruitingNCT02502786Phase 2
• Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical ProstatectomyStatus unknownNCT02452307Phase 1/2
• Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated PeptidesStatus unknownNCT02429440Phase 1/2
• A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSFCompletedNCT02411786Phase 1
• A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis BCompletedNCT02332473Phase 2
• Effects of Embryogen in RIF PatientsCompletedNCT02250768Phase 4
• Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)Status unknownNCT02243228Phase 2
• Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and OsteosarcomaStatus unknownNCT02173093Phase 1/2
• Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer PatientsCompletedNCT02019524Phase 1
• Rituximab + GM-CSF in Patients With Follicular B-Cell LymphomaCompletedNCT01939730Phase 2
• ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma MultiformeActive, not recruitingNCT01903330Phase 2
• Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE TherapyCompletedNCT01828762Not applicable
• Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk NeuroblastomaActive, not recruitingNCT01757626Phase 1/2
• Use of GM-CSF Treatment in Recurrent Implantation FailureStatus unknownNCT01715974Phase 3
• Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian CancerCompletedNCT01580696Phase 1/2
• A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia GravisStatus unknownNCT01555580Early Phase 1
• Ipilimumab and GMCSF Immunotherapy for Prostate CancerWithdrawnNCT01530984Phase 2
• GM-CSF for Immunomodulation Following Trauma (GIFT) StudyCompletedNCT01495637Phase 4
• Peptide-based Glioma Vaccine IMA950 in Patients With GlioblastomaTerminatedNCT01403285Phase 1
• The Effects of Immunostimulation With GM-CSF or IFN-y on Immunoparalysis Following Human EndotoxemiaCompletedNCT01374711Not applicable
• Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in MelanomaCompletedNCT01363206Phase 2
• Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal CancerCompletedNCT01176552Phase 2
• Novel Interventions in HIV-1 InfectionTerminatedNCT01130376Phase 1
• Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSFCompletedNCT00952237Phase 1
• Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38CompletedNCT00912574Not applicable
• Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)CompletedNCT00880243Phase 3
• Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)CompletedNCT00678054Phase 2
• Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced MelanomaCompletedNCT00616564Phase 2
• Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic AdenocarcinomaCompletedNCT00600002Phase 1
• R-CHOP + GM-CSF for Previously Untreated LCL in ElderlyCompletedNCT00582725Phase 2
• Vaccine Therapy in Treating Patients With Breast CancerCompletedNCT00524277Phase 2

← Granulocyte-Macrophage Colony-Stimulating Factor overview